ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges clinical trial sites face during study startup.
Icon Plc ((ICLR)) has held its Q3 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...
We believe Icon possesses all the necessary elements to maintain a strong position in the late-stage contract research organization market: global capabilities, full-service offerings, extensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback